Small Pharma is evaluating the best way to administer N,N-dimethyltryptamine (DMT) in a therapeutic setting for the treatment of depressive disorders. DMT—the primary psychoactive compound in ...
Zacks Investment Research on MSN
Here's how VKTX's obesity drug is moving quickly through phase III
Viking Therapeutics VKTX is one of the few companies with a late-stage obesity candidate in its pipeline. The company is ...
Covid-19 vaccinations have tempered the pandemic’s spread in the U.S., but infections are still happening and not everyone is eligible for the authorized shots. Those needing a Covid antibody ...
Panelists discuss how thoughtful sequencing of antipsychotics enhances adherence, safety, and long-term efficacy. Panelists ...
As medical weight loss continues to evolve in 2026, the landscape of GLP-1 therapies has reached a pivotal moment with ...
Keytruda, a Merck cancer immunotherapy that has become the world’s top-selling medication, is administered as an intravenous infusion over the course of 30 minutes. The pharmaceutical giant now has ...
And for patients facing extreme limitations to mobility, or who live vast distances from hospitals and clinics, mobile ...
Please provide your email address to receive an email when new articles are posted on . NDS-ECNW has obtained a U.S. patent for its Trimoxi injectable formulation for prophylaxis after cataract ...
Access Pharmaceuticals, Inc. (OTCBB: ACCP), announced today that it has entered into a pre-licensing feasibility agreement with a leading biotechnology company to develop an oral formulation of its ...
In 2020, more than 1.5 million people around the world died of tuberculosis, marking the first time in more than a decade that annual TB deaths had increased and demonstrating the global need for ...
DUBLIN--(BUSINESS WIRE)--The "Trunk Injection Technology 2018" report has been added to ResearchAndMarkets.com's offering. Although the trunk injection industry is relatively small, it is showing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results